NCT00075881View on ClinicalTrials.gov

Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Interventions
DRUG

bortezomib

Given IV

OTHER

laboratory biomarker analysis

Optional correlative studies

Trial Locations (1)

02215

Eastern Cooperative Oncology Group, Boston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00075881 - Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma | Biotech Hunter | Biotech Hunter